News
Presented at EuroPCR 2025, the 10-year results of the DANAMI-3-PRIMULTI trial show how complete revascularisation cuts ...
Discover a Phase 3 trial that evaluated stapokibart as an additional therapy for adults with moderate-to-severe seasonal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback